Speaker Profile
Ph.D., CEO, MyOme
Biography
Premal Shah, Ph.D., is the CEO of MyOme, a genomics innovation company focused on preventive health through whole genome sequencing and polygenic risk scoring. With over 20 years of experience in biotech and healthcare, he is dedicated to advancing personalized medicine and genomics-driven health solutions. Previously, Premal was Co-Founder President at Ciitizen, a digital health company empowering patients with their own health data, where he oversaw operations and strategic development, including go-to-market strategies. Ciitizen was acquired by Invitae. Before Ciitizen, he served as CEO of Applied Proteomics, a company pioneering a blood-based colorectal cancer diagnostic test. Prior to that, he led corporate development at Genomic Health (now part of Exact Sciences). Premal began his career as a management consultant at Booz Company, focusing on front-office strategies. He holds a Ph.D. in computational biology from the California Institute of Technology, with several publications in the field.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair: Burns Blaxall
PMWC Award Ceremony Honorees
• Euan Ashley, Stanford
• Jeff Balser, VUMC
Precision Medicine at Scale, Lessons from Vanderbilt
• Jeffrey R. Balser, Vanderbilt
Implementing Precision Medicine at Scale: Health Systems and Policy Perspectives
• Jeffrey Balser, Vanderbilt
• Euan Ashley, Stanford
• Sasa Jenko, European Commission
Keynote
• Lee Hood, Phenome Health
Keys to Successful Implementation of a Precision Medicine Program
• Chair: Howard McLeod, GeneDx
• David E. Lanfear, Henry Ford Health
• Kevan Simms, Ochsner Health
Key Players in Successful Implementation – Beyond Oncology
• Chair: Damon Hostin, Illumina
• Shaista Malik, UC Irvine
Precision Medicine at Scale: Lessons from a Statewide Genomic Initiative
• Chair: Premal Shah, MyOme
Achieving Comprehensive Precision Medicine
• Chair: Burns Blaxall
• Trish Brown, GeneDx
• Sarah Hersey, BMS
• Euan Ashley, Stanford
